1. 15PATM loss in NSCLC increases sensitivity to cisplatin and PARP inhibition. (27th February 2019) Authors: Bebb, D G; Petersen, L F; Moore, J; Elegbede, A; Lees-Miller, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗